An entorhinal-visual cortical circuit regulates depression-like behaviors
- PMID: 35388184
- DOI: 10.1038/s41380-022-01540-8
An entorhinal-visual cortical circuit regulates depression-like behaviors
Erratum in
-
Correction: An entorhinal-visual cortical circuit regulates depression-like behaviors.Mol Psychiatry. 2022 Sep;27(9):3821. doi: 10.1038/s41380-022-01584-w. Mol Psychiatry. 2022. PMID: 35474105 No abstract available.
Abstract
Major depressive disorder is viewed as a 'circuitopathy'. The hippocampal-entorhinal network plays a pivotal role in regulation of depression, and its main sensory output, the visual cortex, is a promising target for stimulation therapy of depression. However, whether the entorhinal-visual cortical pathway mediates depression and the potential mechanism remains unknown. Here we report a cortical circuit linking entorhinal cortex layer Va neurons to the medial portion of secondary visual cortex (Ent→V2M) that bidirectionally regulates depression-like behaviors in mice. Analyses of brain-wide projections of Ent Va neurons and two-color retrograde tracing indicated that Ent Va→V2M projection neurons represented a unique population of neurons in Ent Va. Immunostaining of c-Fos revealed that activity in Ent Va neurons was decreased in mice under chronic social defeat stress (CSDS). Both chemogenetic inactivation of Ent→V2M projection neurons and optogenetic inactivation of the projection terminals induced social deficiency, anxiety- and despair-related behaviors in healthy mice. Chemogenetic inactivation of Ent→V2M projection neurons also aggravated these depression-like behaviors in CSDS-resilient mice. Optogenetic activation of Ent→V2M projection terminals rapidly ameliorated depression-like phenotypes. Optical recording using fiber photometry indicated that elevated neural activity in Ent→V2M projection terminals promoted antidepressant-like behaviors. Thus, the Ent→V2M circuit plays a crucial role in regulation of depression-like behaviors, and can function as a potential target for treating major depressive disorder.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
References
-
- James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.
-
- O’Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208–16. - PubMed
-
- Downar J, Daskalakis ZJ. New targets for rTMS in depression: A review of convergent evidence. Brain Stimulation. 2013;6:231–40. - PubMed
-
- Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): A randomised non-inferiority trial. Lancet. 2018;391:1683–92. - PubMed
-
- Chase HW, Boudewyn MA, Carter CS, Phillips ML. Transcranial direct current stimulation: A roadmap for research, from mechanism of action to clinical implementation. Mol Psychiatry. 2020;25:397–407. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
